Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DUVELISIB for Diffuse large b-cell lymphoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 7 adverse event reports in the FDA FAERS database where DUVELISIB was used for Diffuse large b-cell lymphoma.

Most Reported Side Effects for DUVELISIB

Side Effect Reports % Deaths Hosp.
Product use in unapproved indication 162 21.4% 32 54
Diarrhoea 110 14.5% 8 47
Death 89 11.8% 87 13
Fatigue 75 9.9% 5 24
Prescribed underdose 63 8.3% 8 18
Off label use 57 7.5% 4 8
Nausea 49 6.5% 6 20
Pneumonia 40 5.3% 15 27
Pyrexia 40 5.3% 3 21
Malignant neoplasm progression 38 5.0% 15 20
Rash 33 4.4% 2 8
Hospitalisation 32 4.2% 4 30
Asthenia 30 4.0% 1 13
Vomiting 30 4.0% 5 20
Disease progression 28 3.7% 15 11

Other Indications for DUVELISIB

Chronic lymphocytic leukaemia (156) Peripheral t-cell lymphoma unspecified (111) B-cell lymphoma (87) Non-hodgkin's lymphoma (59) Angioimmunoblastic t-cell lymphoma (54) Product used for unknown indication (38) Cutaneous t-cell lymphoma (37) Follicular lymphoma (28) T-cell lymphoma (18) Lymphocytic leukaemia (14)

Other Drugs Used for Diffuse large b-cell lymphoma

RITUXIMAB (22,275) CYCLOPHOSPHAMIDE (16,598) DOXORUBICIN (15,213) VINCRISTINE (14,922) PREDNISONE (11,266) LENALIDOMIDE (7,858) ETOPOSIDE (4,698) PREDNISOLONE (4,086) CYTARABINE (3,857) DEXAMETHASONE (3,696)

Related Pages

DUVELISIB Full Profile All Diffuse large b-cell lymphoma Drugs DUVELISIB Demographics DUVELISIB Timeline